EUVIMEDDescubrir EUVIMED
Systematische ÜbersichtOpen access

Economic Evaluations of Digital Health Interventions for Patients With Heart Failure: Systematic Review

Ökonomische Bewertungen digitaler Gesundheitsinterventionen für Patient:innen mit Herzinsuffizienz: systematische Übersichtsarbeit

Neily Zakiyah iD, Dita Marulin iD, Mohammed Alfaqeeh iD, Irma Melyani Puspitasari iD, Keri Lestari iD, Ka Keat Lim iD, Julia Fox-Rushby iD

Journal of Medical Internet Research · 2024-04-30 · 26 · e53500

DOI: 10.2196/53500 ↗

Auf einen Blick

Die Übersichtsarbeit fasste 27 ökonomische Bewertungen zu digitalen Gesundheitsinterventionen bei Herzinsuffizienz zusammen. Insgesamt zeigten die meisten Studien kosteneffektive Ergebnisse, teils auch dominante Strategien.

Fragestellung

Wie kosteneffektiv sind digitale Gesundheitsinterventionen bei der Behandlung und Versorgung von Patient:innen mit Herzinsuffizienz?

Methode

Systematische Übersichtsarbeit mit narrativer Synthese; 3 Datenbanken bis Juli 2023; Bewertung der Berichtsqualität mit CHEERS.

Ergebnisse

27 ökonomische Bewertungen: 13 modellbasiert, 13 auf Studienbasis, 1 kombiniert. 24/27 nutzten Kosten-Nutzen-Analysen. Mobile Apps, Wearables, Follow-up bei implantierbaren Geräten und Videokonferenzen zeigten meist kosteneffektive oder dominante Ergebnisse.

Einschränkungen

Widersprüchliche Ergebnisse, besonders bei nichtinvasiven Fernüberwachungsgeräten und telefonischer Unterstützung.

Schlussfolgerung der Autor:innen

Trotz widersprüchlicher Ergebnisse deuten die Hauptbefunde insgesamt darauf hin, dass DHIs kosteneffektiver waren als Nicht-DHI-Alternativen.

Kernaussagen

  • 27 ökonomische Bewertungen zu DHIs bei Herzinsuffizienz
  • Meist kosteneffektive Ergebnisse; teils dominante Strategien
  • Widerspruch vor allem bei Fernüberwachung und Telefonunterstützung

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Systematische Übersicht in Journal of Medical Internet Research, published online on 2024-04-30. Written by Neily Zakiyah and 6 co-authors. Institution: Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia. Major MEDLINE topics: Digital Health, Heart Failure, Telemedicine. Cited 29 times so far (Crossref); 72 references. The full text is freely available in PubMed Central.

Auf einen BlickResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Background

Digital health interventions (DHIs) have shown promising results in enhancing the management of heart failure (HF). Although health care interventions are increasingly being delivered digitally, with growing evidence on the potential cost-effectiveness of adopting them, there has been little effort to collate and synthesize the findings.

Objective

This study’s objective was to systematically review the economic evaluations that assess the adoption of DHIs in the management and treatment of HF.

Methods

A systematic review was conducted using 3 electronic databases: PubMed, EBSCOhost, and Scopus. Articles reporting full economic evaluations of DHIs for patients with HF published up to July 2023 were eligible for inclusion. Study characteristics, design (both trial based and model based), input parameters, and main results were extracted from full-text articles. Data synthesis was conducted based on the technologies used for delivering DHIs in the management of patients with HF, and the findings were analyzed narratively. The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were followed for this systematic review. The reporting quality of the included studies was evaluated using the CHEERS (Consolidated Health Economic Evaluation Reporting Standards) guidelines.

Results

Overall, 27 economic evaluations were included in the review. The economic evaluations were based on models (13/27, 48%), trials (13/27, 48%), or a combination approach (1/27, 4%). The devices evaluated included noninvasive remote monitoring devices (eg, home telemonitoring using digital tablets or specific medical devices that enable transmission of physiological data), telephone support, mobile apps and wearables, remote monitoring follow-up in patients with implantable medical devices, and videoconferencing systems. Most of the studies (24/27, 89%) used cost-utility analysis. The majority of the studies (25/27, 93%) were conducted in high-income countries, particularly European countries (16/27, 59%) such as the United Kingdom and the Netherlands. Mobile apps and wearables, remote monitoring follow-up in patients with implantable medical devices, and videoconferencing systems yielded cost-effective results or even emerged as dominant strategies. However, conflicting results were observed, particularly in noninvasive remote monitoring devices and telephone support. In 15% (4/27) of the studies, these DHIs were found to be less costly and more effective than the comparators (ie, dominant), while 33% (9/27) reported them to be more costly but more effective with incremental cost-effectiveness ratios below the respective willingness-to-pay thresholds (ie, cost-effective). Furthermore, in 11% (3/27) of the studies, noninvasive remote monitoring devices and telephone support were either above the willingness-to-pay thresholds or more costly than, yet as effective as, the comparators (ie, not cost-effective). In terms of reporting quality, the studies were classified as good (20/27, 74%), moderate (6/27, 22%), or excellent (1/27, 4%).

Conclusions

Despite the conflicting results, the main findings indicated that, overall, DHIs were more cost-effective than non-DHI alternatives. Trial Registration PROSPERO CRD42023388241; https://tinyurl.com/2p9axpmc

Subjects

MeSH terms (MEDLINE)

Digital HealthHeart FailureTelemedicineHumansCost-Benefit Analysis

Author keywords

cost-effectivenessdigital healthheart failuremobile phonesystematic reviewtelehealthtelemonitoring

Authors and institutions

  • Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia.
  • Center of Excellence for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia.
  • Department of Population Health Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.

ORCID profiles: Neily Zakiyah, Dita Marulin, Mohammed Alfaqeeh, Irma Melyani Puspitasari, Keri Lestari, Ka Keat Lim, Julia Fox-Rushby

Cite

APA

Zakiyah, N., Marulin, D., Alfaqeeh, M., Puspitasari, I. M., Lestari, K., Lim, K. K., & Fox-Rushby, J. (2024). Economic Evaluations of Digital Health Interventions for Patients With Heart Failure: Systematic Review. Journal of Medical Internet Research, 26, e53500. https://doi.org/10.2196/53500

Vancouver

Zakiyah N, Marulin D, Alfaqeeh M, Puspitasari IM, Lestari K, Lim KK, et al. Economic Evaluations of Digital Health Interventions for Patients With Heart Failure: Systematic Review. Journal of Medical Internet Research. 2024;26:e53500. doi:10.2196/53500

BibTeX
@article{Zakiyah2024,
  author = {Zakiyah, Neily and Marulin, Dita and Alfaqeeh, Mohammed and Puspitasari, Irma Melyani and Lestari, Keri and Lim, Ka Keat and Fox-Rushby, Julia},
  title = {Economic Evaluations of Digital Health Interventions for Patients With Heart Failure: Systematic Review},
  journal = {Journal of Medical Internet Research},
  year = {2024},
  volume = {26},
  pages = {e53500},
  doi = {10.2196/53500}
}
Start for free →